Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Diagnosis and Monitoring of Alzheimer's Disease
NCT01463384Phase 2Completed
- Sponsor
- Huntington Medical Research Institutes
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Huntington Medical Research Institutes. Started Sep 2011; status: completed.
02
Drugs
minocycline
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01463384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01463384.